Key facts
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Elevation Oncology, Inc. Common Stock, par value $0.0001 per share (ELEV).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2025.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 10% | 6,043,921 | 0 | 6,043,921 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 10% | 6,043,921 | 0 | 6,043,921 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 8.4% | 5,052,545 | 0 | 5,052,545 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.91% | 551,376 | 0 | 551,376 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0.73% | 440,000 | 0 | 440,000 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |
CIK / CUSIP context first